Business Context and Reporting Period
Company: Modular Medical, Inc. (MODD)
Filing Type: Form 8-K (Current Report)
Date of Report: December 30, 2025
Reporting Period: Event-based report regarding Nasdaq listing compliance status.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
- Compliance Extension Granted: On December 30, 2025, Nasdaq granted the Company a 180-day extension to regain compliance with the minimum bid price requirement.
- New Compliance Deadline: The Company must meet the $1.00 minimum bid price requirement by June 29, 2026.
- Compliance Condition: To regain compliance, the Common Stock must close at $1.00 or more for a minimum of 10 consecutive business days prior to the deadline.
- Trading Status: The extension has no immediate effect on trading; the stock continues to trade on the Nasdaq Capital Market under the symbol "MODD."
Outlook, Risks, and Management Commentary
- Delisting Risk: If the Company fails to regain compliance by June 29, 2026, Nasdaq will notify the Company of delisting.
- Appeal Process: In the event of a delisting determination, the Company may appeal to a hearings panel, though success is not assured.
- Management Action: The Company intends to monitor the closing bid price and evaluate available options to regain compliance.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ due to risks, including the inability to meet minimum bid price requirements or Nasdaq listing rules.
Investor Verification Checklist
- Verify the current closing bid price of MODD stock relative to the $1.00 threshold.
- Monitor the stock's performance over the next 10 consecutive business days to assess immediate compliance progress.
- Review the Company's most recent Form 10-K and 10-Q for underlying financial reasons contributing to the low stock price.
- Watch for future 8-K filings regarding potential reverse stock splits or other corporate actions intended to raise the share price.
- Confirm the status of any appeal if the June 29, 2026 deadline is missed.